Martin Pasek

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

Crescent Healthcare, Inc. provides home infusion services to patients with chronic disorders. The company was founded in 1992 and is headquartered in Deerfield, IL.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Pangaea Ventures Ltd(Pangaea Ventures) is a venture capital firm founded in 2000 by Chris Erickson. The firm is headquartered in Vancouver, British Columbia, Canada.

Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC.

Cardinal Health 414 provides radio pharmacy services. It offers solutions, which are used in compounding, delivery, safety, consulting, information technology and business support services. The firm offers services in regulatory compliance, reimbursement, practice development, continuing education and information management. The company was founded in April, 2003 and is headquartered in Dublin, OH.

Renal Physicians Association is a non-profit national medical association that specializes in nephrology. The private company is based in Rockville, MD.

Plaxica Ltd. develops a new generation of polymers derived from sustainable resources. The firm's technology allows polylactic acid to replace traditional polymers produced from oil. The company was founded by John Edward Hamlin, Edward Leslie Marshall and Vernon C. Gibson in 2008 and is headquartered in Redcar, the United Kingdom.

Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland.

Diabetic Care Rx LLC provides customized nutritional therapy to patients with end stage renal disease. It focuses on providing patient-specific IDPN and IPN therapies that can help increase a patient’s Serum Albumin and decrease the risk of fluid retention, inflammation, infection, hospitalizations, mortality and morbidity. The firm’s pharmacists deliver patient-specific nutritional formulations based on nutritional lab values provided by renal dietitians. Its services include NutriTrak, NutriPlan 7 Oral Protein Jumpstart, Patient Plus and Clinical Support. The company was founded in 2004 and is headquartered in Pompano Beach, FL.

Polymetrix AG designs, supplies, and installs industrial plants for the thermal treatment of bulk materials primarily for producing virgin and recycled polyesters, polyamides (PA), and other polymers worldwide. The firm builds various plants in the fields of PET recycling, polyamide conditioning, solid state polycondensation (SSP), and polybutylene terephthalate (PBT). It also provides consulting services in the fields of process optimization and extension or conversion of existing plants, engineering and EPCm services, such as project management, proprietary equipment design, basic und detail engineering, automation, procurement and logistics and quality assurance and checks and construction management and services and testing programs, which include consulting for food approvals, material evaluation and testing, process simulation, plant retrofit services, continuous pilot plant testing and on-site support. The company was founded in 2012 and is headquartered in Oberburen, Switzerland.

DaVita Kidney Care provides kidney care services. It delivers dialysis services to patients with chronic kidney failure and end stage renal diseases. The company was founded in 1999 and is headquartered in Denver, CO.

Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019.

INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018.